Silicon Canals
No Result
View All Result
  • Home
  • News
    • News
    • Startups
    • Scaleups
    • Coin Canals
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Event News
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Exclusive content
    • Partner content
    • Community partners
    • Amsterdam
    • Rise by Techleap.nl
    • EOR handbook by Atlas HXM
    • Guest Contributions
    • Business Wire
    • Sign up for our newsletter!
  • Global Jobs
  • Tech Events
    • Technology Events
    • Event News
    • Submit event
  • Contact
    • Contact us
    • Contribute your content
    • Team
    • About us
  • Partner with us
  • Home
  • News
    • News
    • Startups
    • Scaleups
    • Coin Canals
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Event News
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Exclusive content
    • Partner content
    • Community partners
    • Amsterdam
    • Rise by Techleap.nl
    • EOR handbook by Atlas HXM
    • Guest Contributions
    • Business Wire
    • Sign up for our newsletter!
  • Global Jobs
  • Tech Events
    • Technology Events
    • Event News
    • Submit event
  • Contact
    • Contact us
    • Contribute your content
    • Team
    • About us
  • Partner with us
No Result
View All Result
Silicon Canals
No Result
View All Result

Swiss-based Comphya announces successful implantation of device to address erectile dysfunction

Vignesh R. by Vignesh R.
August 21, 2023
in Health & Medtech, News, Startups
Comphya CEO

In the image: Rodrigo Fraga-Silva, CEO and Co-founder of Comphya| Image credits: Comphya

15
SHARES
LinkedInTwitterWhatsAppFacebook
Read this article in:

In a first, Lausanne, Switzerland-based medical device company Comphya announced on Monday the successful implantation of a high-tech, battery-powered device to restore erectile function.

The company has developed CaverSTIM, the first implantable device to address erectile dysfunction in patients who do not respond to oral medications. 

This group includes patients who have suffered spinal cord injuries and those who have undergone prostate removal surgery, also known as post-prostatectomy patients.

The successful transplant took place at the Royal Melbourne Hospital (RMHin Melbourne, Australia. 

- Partner content -
Atlas HXM EOR Employee of Record
How EOR is becoming a crucial tool in 2023
EOR gains importance as companies digitise and hire globally. Learn from industry leaders...Show More
EOR gains importance as companies digitise and hire globally. Learn from industry leaders using EOR with Atlas HXM.Show Less
Read more

Dr Phil Dundee, Consulting Urologist at the RMH and Clinical Director at the Australian Prostate Centre (APC),, conducted the successful operation on August 3. 

“It’s truly exciting to be part of such innovation particularly when we know this treatment has the potential to be life-changing for millions of patients worldwide,” says Dr. Dundee.

The first-in-human clinical safety trial for the ground-breaking treatment is a collaboration between the APC, the RMH and Comphya SA.

What does Comphya solve?

Currently, patients dealing with erectile dysfunction often resort to intrapenile injections or penile implants as the only available treatment options. However, these methods are known to be painful, problematic, and outdated.

Here’s where Comphya’s patented solution offers a unique and superior treatment for erectile dysfunction. 

The Swiss company’s primary objective is to restore physiological sexual function and enhance the quality of life for a significant portion of the male population in dire need of such solutions.

Comphya
Image credits: Comphya

What do you need to know about CaverSTIM?

CaverSTIM is a ‘neurostimulation’ system composed of an implantable pulse generator (IPG). The device contains a rechargeable battery and electronics responsible for generating an electrostimulation signal.

The device is implanted within the pelvic cavity where it activates and restores the nerves that play a crucial role in penile erection.

The IPG, once surgically inserted in the lower abdomen, is remotely operated by external controllers.

The clinician controller allows medical professionals to adjust and customise the system’s parameters to suit each patient’s unique needs. 

The patient controller puts the power in the hands of the patient, allowing them to activate the device and trigger a penile erection.

“As we initiate this clinical trial, we celebrate the culmination of our team’s steadfast dedication and hard work in developing our unique CaverSTIM system,” says Rodrigo Fraga-Silva, CEO and Co-founder of Comphya SA.

 - Partner content -
How to succesfully outsource…
How to succesfully outsource…
...your recruitment or product development with our curated community partners!
...your recruitment or product development with our curated community partners! Show Less
Read more
Tags: medtechnewsstartups
Share1Tweet4SendShare6

Partner with us | Download Media Kit

Thank you for visiting Silicon Canals! If you want to partner with us, look at our options.

Featured | Tech Events

Current Month

october, 2023

Silicon Canals | Jobs

Breaking news from Amsterdam | Partner

Amsterdam’s Invest-NL backs Extantia Capital’s decarbonisation mission with €10M investment

Amsterdam’s SET Ventures launches €200M; aims to back these many European energy startups

Amsterdam’s Invest-NL takes center stage in protecting Dutch companies from unwanted takeovers: Here’s how

Partner content | Work with us

Invest-NL secures €350M in guarantees for Dutch sustainable ventures through InvestEU partnership: Know more

Looking for a job in Amsterdam? These unicorns are hiring currently hiring

Amsterdam’s hypeal.com raises €188K to reshape the way digital assets are utilised

  • About Silicon Canals
  • Partner with Silicon Canals
  • Impressum
  • Contact us
  • Sign up for our newsletter!
  • Disclaimer
  • Privacy Policy
  • Cookie Policy (UK)
  • Cookie Policy (EU)
  • Terms & Conditions Silicon Canals

Silicon Canals © 2014-2023 | Design: Bright Idiots. Images: Depositphotos

No Result
View All Result
  • Home
  • News
    • News
    • Startups
    • Scaleups
    • Coin Canals
    • FinTech
    • AI and chatbots
    • Travel & Mobility
    • Software & SaaS
    • Event News
    • Health & Medtech
    • (Crowd)funding
    • Blockchain
    • Internet of things
    • Hardware
    • Accelerators
    • E-commerce
    • Cybersecurity
    • Gaming & Virtual Reality
    • Drones
  • Exclusive content
    • Partner content
    • Community partners
    • Amsterdam
    • Rise by Techleap.nl
    • EOR handbook by Atlas HXM
    • Guest Contributions
    • Business Wire
    • Sign up for our newsletter!
  • Global Jobs
  • Tech Events
    • Technology Events
    • Event News
    • Submit event
  • Contact
    • Contact us
    • Contribute your content
    • Team
    • About us
  • Partner with us

Silicon Canals © 2014-2023 | Design: Bright Idiots. Images: Depositphotos

X
X